This brand name is authorized in Ecuador, Mexico, Spain, Turkey.
The drug PEITEL contains one active pharmaceutical ingredient (API):
1
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D07AC18 | Prednicarbate | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III) |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 29147-01-10 |
| ES | Centro de información online de medicamentos de la AEMPS | 60370, 60371, 60372, 60393 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 424M2016 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699587354099 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.